NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX.
Post# of 87
(Total Views: 627)
Posted On: 04/01/2019 4:17:51 PM
NetworkNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives Second Site License from Health Canada
Dynamic plant-based food and beverage company Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, James E. Wagner Cultivation Corporation (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF), has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (“JWC2”). Per the update, reception of this license will result in the launch of the initial phase of JWC2, a 345,000-square-foot production and distribution complex through which JWC intends to roll out more than 130 individual production rooms utilizing its proprietary GrowthSTORM Dual Droplet cultivation platform and methodologies. “While optimizing production methodologies at their already licenced pilot facility, JWC has concurrently built out and implemented refinements and learnings for production at commercial scale,” Daniel Pearlstein, Canopy Rivers’ executive vice president of strategy, stated in the news release. “We are pleased to see Health Canada reward JWC for the quality of their operations, and their disciplined approach to expansion with the issuance of this second site licence.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Dynamic plant-based food and beverage company Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, James E. Wagner Cultivation Corporation (“JWC”) (TSX.V: JWCA) (OTCQX: JWCAF), has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (“JWC2”). Per the update, reception of this license will result in the launch of the initial phase of JWC2, a 345,000-square-foot production and distribution complex through which JWC intends to roll out more than 130 individual production rooms utilizing its proprietary GrowthSTORM Dual Droplet cultivation platform and methodologies. “While optimizing production methodologies at their already licenced pilot facility, JWC has concurrently built out and implemented refinements and learnings for production at commercial scale,” Daniel Pearlstein, Canopy Rivers’ executive vice president of strategy, stated in the news release. “We are pleased to see Health Canada reward JWC for the quality of their operations, and their disciplined approach to expansion with the issuance of this second site licence.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼